Pacira BioSciences, Inc. PCRX Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Pacira BioSciences, Inc. (PCRX) reported accretion (amortization) of discounts and premiums, investments of $570K in Q1 2026.
- How has Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Pacira BioSciences, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 70.2% year-over-year, from $1.91M to $570K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Captures the non-cash adjustment to the carrying value of investment securities resulting from the amortization of premiums or accretion of discounts. This ensures that the interest income recognized on the income statement aligns with the effective interest method over the life of the investment.